Belgian drugmaker wins approval to enter competitive US market for rheumatoid arthritis drugs

WASHINGTON — Belgian drugmaker UCB said Wednesday it received federal approval for an injectable drug to treat arthritis, entering a competitive market dominated by some of the largest U.S. pharmaceutical companies.

Poll

Do you think Barack Obama is a good choice for Nobel Peace Prize

View Results

Comments

Show all Polls
Loading ... Loading ...
Protected by Comment Guard Pro